Association Between e-Cigarette Use and Depression in the Behavioral Risk Factor Surveillance System, 2016-2017.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
02 12 2019
02 12 2019
Historique:
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
24
6
2020
Statut:
epublish
Résumé
The prevalence of the use of electronic cigarettes (e-cigarettes) in the United States has grown rapidly since their introduction to the market more than a decade ago. While several studies have demonstrated an association between combustible cigarette smoking and depression, the association between e-cigarette use and depression has not been thoroughly studied. To examine the association between e-cigarette use and depression in a nationally representative sample of the adult population in the United States. Cross-sectional study of the Behavioral Risk Factor Surveillance System database, 2016 to 2017. The Behavioral Risk Factor Surveillance System is the largest national telephone-based survey of randomly sampled adults in the United States. A total of 892 394 participants with information on e-cigarette use and depression were included. Data analysis was conducted in May 2019. Electronic cigarette use status defined by self-report as never, former, or current use. Self-reported history of a clinical diagnosis of depression. Of the 892 394 participants (414 326 [29.0%] aged ≥60 years; 502 448 [51.3%] women), there were 28 736 (4.4%) current e-cigarette users, of whom 13 071 (62.1%) were aged between 18 and 39 years. Compared with never e-cigarette users, current e-cigarette users were more likely to be single, male, younger than 40 years, and current combustible cigarette smokers (single, 120 797 [24.3%] vs 10 517 [48.4%]; men, 318 970 [46.6%] vs 14 962 [60.1%]; aged 18-39 years, 129 085 [32.2%] vs 13 071 [62.1%]; current combustible cigarette use, 217 895 [7.9%] vs 8823 [51.8%]). In multivariable adjusted models, former e-cigarette users had 1.60-fold (95% CI, 1.54-1.67) higher odds of reporting a history of clinical diagnosis of depression than never users, whereas current e-cigarette users had 2.10 (95% CI, 1.98-2.23) times higher odds. Additionally, higher odds of reporting depression were observed with increased frequency of use among current e-cigarette users compared with never users (daily use: odds ratio, 2.39; 95% CI, 2.19-2.61; occasional use: odds ratio, 1.96; 95% CI, 1.82-2.10). Similar results were seen in subgroup analyses by sex, race/ethnicity, smoking status, and student status. This study found a significant cross-sectional association between e-cigarette use and depression, which highlights the need for prospective studies analyzing the longitudinal risk of depression with e-cigarette use. If confirmed by other study designs, the potential mental health consequences may have regulatory implications for novel tobacco products.
Identifiants
pubmed: 31800073
pii: 2756260
doi: 10.1001/jamanetworkopen.2019.16800
pmc: PMC6902792
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1916800Subventions
Organisme : NHLBI NIH HHS
ID : P50 HL120163
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL120163
Pays : United States
Références
Prev Med. 2016 Dec;93:14-20
pubmed: 27612572
JAMA Pediatr. 2017 Aug 1;171(8):788-797
pubmed: 28654986
Clin Pharmacokinet. 1999 Jun;36(6):425-38
pubmed: 10427467
J Am Acad Child Adolesc Psychiatry. 1996 Dec;35(12):1602-10
pubmed: 8973066
Subst Abus. 2019;40(1):7-10
pubmed: 30883295
PLoS One. 2019 Aug 8;14(8):e0220763
pubmed: 31393922
Ann Intern Med. 2018 Oct 2;169(7):429-438
pubmed: 30167658
JAMA Pediatr. 2017 Mar 1;171(3):209-210
pubmed: 27928577
Tob Control. 2014 Mar;23(2):133-9
pubmed: 23467656
N Engl J Med. 2011 Jul 21;365(3):196-8
pubmed: 21774707
Environ Res. 2018 Oct;166:269-275
pubmed: 29908458
JAMA. 2000 Aug 9;284(6):699-705
pubmed: 10927777
Psychiatr Serv. 2008 Dec;59(12):1383-90
pubmed: 19033164
BMJ Case Rep. 2018 Oct 2;2018:null
pubmed: 30279252
Environ Health Perspect. 2018 Feb 21;126(2):027010
pubmed: 29467105
Annu Rev Clin Psychol. 2009;5:409-31
pubmed: 19327035
Drug Alcohol Depend. 2013 Aug 1;131(3):214-21
pubmed: 23746429
Addict Behav. 2019 Mar;90:85-91
pubmed: 30368023
Ann N Y Acad Sci. 2015 Mar;1340:65-74
pubmed: 25557889
Addict Behav. 2009 Jun-Jul;34(6-7):491-7
pubmed: 19217720
J Am Heart Assoc. 2018 Jul 14;7(14):
pubmed: 30007934
Tob Control. 2014 May;23 Suppl 2:ii30-5
pubmed: 24732160
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Ann Intern Med. 2019 Jan 1;170(1):70-71
pubmed: 30304343
Lancet Psychiatry. 2018 Sep;5(9):739-746
pubmed: 30099000
Tob Control. 2019 Nov;28(6):623-628
pubmed: 30733312
Biol Trace Elem Res. 2019 Apr;188(2):295-315
pubmed: 29974385
J Addict Dis. 1998;17(1):35-46
pubmed: 9549601
J Gen Physiol. 2019 Jun 3;151(6):714-717
pubmed: 30902836
Inhal Toxicol. 2018 Feb;30(2):78-88
pubmed: 29564955
Tob Control. 2014 Jul;23 Suppl 3:iii48-53
pubmed: 24824516
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
Int J Environ Res Public Health. 2016 Dec 23;14(1):
pubmed: 28025560
Prev Med. 2017 Mar;96:73-78
pubmed: 28024859
JAMA. 1990 Sep 26;264(12):1546-9
pubmed: 2395194
BMJ. 2015 Sep 21;351:h4065
pubmed: 26391240